Dognosis developed BreathEasy, an innovative test that analyzes patients' breath to detect signs of cancer. The system uses a combination of trained dogs, advanced sensors and artificial intelligence to identify the presence of the disease.
In a Phase 2 study, BreathEasy demonstrated promising results, managing to identify seven different cancer groups with an accuracy rate of approximately 91%.
This approach represents a non-invasive methodology for cancer screening and early detection, using the dogs' keen sense of smell as part of a broader technological system.
